Impaired SARS-CoV-2-specific T-cell reactivity in patients with cirrhosis following mRNA COVID-19 vaccination

BACKGROUND & AIMS: Cirrhosis entails elevated risk of COVID-19-associated mortality. This study determined T cell-mediated and antibody reactivity against the spike 1 (S1) protein of SARS-CoV-2 among 48 patients with cirrhosis and 39 healthy controls after mRNA COVID-19 vaccination. METHODS: SAR...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Dury, Samer, Waern, Johan, Waldenström, Jesper, Alavanja, Marko, Saed, Hevar Hamah, Törnell, Andreas, Arabpour, Mohammad, Wiktorin, Hanna Grauers, Einarsdottir, Sigrun, Ringlander, Johan, Ringström, Gisela, Hellstrand, Kristoffer, Martner, Anna, Lagging, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045869/
https://www.ncbi.nlm.nih.gov/pubmed/35502229
http://dx.doi.org/10.1016/j.jhepr.2022.100496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045869/
https://www.ncbi.nlm.nih.gov/pubmed/35502229
http://dx.doi.org/10.1016/j.jhepr.2022.100496

Ejemplares similares